Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double- blind randomised placebo- controlled study (RAPID-PsA)
Author(s):
Mease, P.J.; Fleischmann, R.; Deodhar, A.A.; Wollenhaupt, J.; Khraishi, M.; Kielar, D.; Woltering, F.; Stach, C.; Hoepken, B.; Arledge, T.; Heijde, D. van der
Published
2014
Publication type
Article / Letter to editor
Anti-TNFTreatmentPsoriatic Arthritis
Date issued
2014-01-31
Language
English
Is part of
Annals of the Rheumatic Diseases (2014), Vol. 73, no. 1, p. 48-55
